Upstream process intensification using perfusion cell culture has become a necessity for meeting today’s demand in monoclonal antibodies (mAbs) bioprocessing. By sustaining higher viable cell ...
Upstream’s Relatively Continuous Flows Raise Hopes for Continuous Purification Perfusion culture has been employed for at least 20 years in bioprocessing, but it is now catching on as the upstream ...
WALTHAM, Mass., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Sartorius and Repligen Corporation (NASDAQ:RGEN) today announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF ...
The biopharmaceutical industry is expanding rapidly, driven by an increasing demand for complex biomedicines. Today, manufacturing biomolecules presents unique challenges, like cost pressure and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback